ARTICLE | Clinical News
TOBI Podhaler regulatory update
April 1, 2013 7:00 AM UTC
The U.K.'s NICE issued final guidance recommending TOBI Podhaler from Novartis to treat chronic pulmonary infection caused by Pseudomonas aeruginosa in cystic fibrosis patients if nebulized tobramycin...